Publication
Structural Analysis of Pathogenic Missense Mutations in GABRA2 and Identification of a Novel de Novo Variant in the Desensitization Gate
dc.contributor.author | Sanchis-Juan, A | |
dc.contributor.author | Hasenahuer, MA | |
dc.contributor.author | Baker, JA | |
dc.contributor.author | McTague, A | |
dc.contributor.author | Barwick, K | |
dc.contributor.author | Kurian, MA | |
dc.contributor.author | Duarte, ST | |
dc.contributor.author | Carss, KJ | |
dc.contributor.author | Thornton, J | |
dc.contributor.author | Raymond, FL | |
dc.date.accessioned | 2021-05-27T08:18:02Z | |
dc.date.available | 2021-05-27T08:18:02Z | |
dc.date.issued | 2020 | |
dc.description.abstract | Background: Cys-loop receptors control neuronal excitability in the brain and their dysfunction results in numerous neurological disorders. Recently, six missense variants in GABRA2, a member of this family, have been associated with early infantile epileptic encephalopathy (EIEE). We identified a novel de novo missense variant in GABRA2 in a patient with EIEE and performed protein structural analysis of the seven variants. Methods: The novel variant was identified by trio whole-genome sequencing. We performed protein structural analysis of the seven variants, and compared them to previously reported pathogenic mutations at equivalent positions in other Cys-loop receptors. Additionally, we studied the distribution of disease-associated variants in the transmembrane helices of these proteins. Results: The seven variants are in the transmembrane domain, either close to the desensitization gate, the activation gate, or in inter-subunit interfaces. Six of them have pathogenic mutations at equivalent positions in other Cys-loop receptors, emphasizing the importance of these residues. Also, pathogenic mutations are more common in the pore-lining helix, consistent with this region being highly constrained for variation in control populations. Conclusion: Our study reports a novel pathogenic variant in GABRA2, characterizes the regions where pathogenic mutations are in the transmembrane helices, and underscores the value of considering sequence, evolutionary, and structural information as a strategy for variant interpretation of novel missense mutations. | pt_PT |
dc.description.version | info:eu-repo/semantics/publishedVersion | pt_PT |
dc.identifier.citation | Mol Genet Genomic Med . 2020 Jul;8(7):e1106 | pt_PT |
dc.identifier.doi | 10.1002/mgg3.1106 | pt_PT |
dc.identifier.uri | http://hdl.handle.net/10400.17/3708 | |
dc.language.iso | eng | pt_PT |
dc.peerreviewed | yes | pt_PT |
dc.publisher | Wiley | pt_PT |
dc.subject | Child | pt_PT |
dc.subject | Epilepsy | pt_PT |
dc.subject | Female | pt_PT |
dc.subject | Humans | pt_PT |
dc.subject | Language Disorders | pt_PT |
dc.subject | Molecular Dynamics Simulation | pt_PT |
dc.subject | Protein Domains | pt_PT |
dc.subject | Protein Multimerization | pt_PT |
dc.subject | Receptors, GABA-A | pt_PT |
dc.subject | Stereotyped Behavior | pt_PT |
dc.subject | Ion Channel Gating | pt_PT |
dc.subject | Mutation, Missense | pt_PT |
dc.subject | HDE NEU PEd | pt_PT |
dc.title | Structural Analysis of Pathogenic Missense Mutations in GABRA2 and Identification of a Novel de Novo Variant in the Desensitization Gate | pt_PT |
dc.type | journal article | |
dspace.entity.type | Publication | |
oaire.citation.issue | 7 | pt_PT |
oaire.citation.startPage | e1106 | pt_PT |
oaire.citation.title | Molecular genetics & genomic medicine | pt_PT |
oaire.citation.volume | 8 | pt_PT |
rcaap.rights | openAccess | pt_PT |
rcaap.type | article | pt_PT |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- Mol Genet Genom Med 2020_e1106.pdf
- Size:
- 2.09 MB
- Format:
- Adobe Portable Document Format